Red Book Online Updates and Errata

On February 14, 2025, updates were made to the following chapter:

• Meningococcal Infections

On November 11, 2024, updates were made to the following chapters:

• Immunization in American Indian/Alaska Native Children and Adolescents 
• Haemophilus influenzae Infections 

February 26, 2025:

• Page 524: In Figure 3.13 in the “Kawasaki Disease” chapter, the box that reads: CRP ≥3.0 mg/dL and ESR ≥40 mm/hr has been updated to read: CRP ≥3.0 mg/dL and/or
  ESR ≥40 mm/hr. The figure has been updated on Red Book Online and a revised page 524 appears on page on page 4 of this Errata. View the Errata.

July 24, 2024:

• Page 813: In Table 3.68 in the “Streptococcus pneumoniae (Pneumococcal) Infections” chapter, the breakpoint for CEFOTAXIME OR CEFTRIAXONE in the Meningitis listing under the first column, “Susceptible” has been corrected from <0.5 to ≤0.5. The table has been updated on Red Book Online and a revised page 813 appears on page 2 of this Errata. View the Errata.

• Page xxxvii, Summary of Major Changes in the 2024 Red Book, entry #2: “The listing below outlines the more major changes throughout the 2014” corrected to The listing below outlines the more major changes throughout the 2024 edition.”
• Page 71, Active Immunization: “graded increase in vaccine dose that is administration” corrected to “graded increase in vaccine dose administered”
• Page 330, Coronavirus Disease 2019 (COVID-19): “People eligible for additional doses include are those” corrected to “People eligible for additional doses include those”
• Page 450, Hepatitis B chapter, Figure 3.5: footnote "a" reference added in the text box (third box down at far left of figure) to read: “Hepatitis B vaccine^a and HBIG within 12 hours of birth”
• Page 461, Hepatitis C chapter, Figure 3.6: footnote updated from “Modified Conners EE, Panagiotakopoulos L, Hofmeister MG, et al. Screening and testing for hepatitis B virus infection: CDC recommendations—United States, 2023. MMWR Recomm Rep. 2023;72(RR-1):1-25.” to “Modified from Panagiotakopoulos L, Sandul AL, Conners EE, Foster MA, Nelson NP, Wester C. CDC recommendations for hepatitis C testing among perinatally exposed infants and children—United States, 2023. MMWR Recomm Rep. 2023;72(RR-4):1-19.” 
• Page 485, Human Herpesvirus 6 (Including Roseola) and 7, “RandBP2” corrected to  “RANBP2”.
• Page 595, Meningococcal B Vaccines, Table 3.40, in section Meningococcal B Vaccines: “Other than outbreak: booster^g” corrected to “Other than outbreak: booster^h”
• Page 637, Parechovirus chapter: “(especially younger than 6 months of age infected with HPeV-6)” corrected to “(especially younger than 6 months of age infected with HPeV-3)”
• Page 851, Tetanus chapter, Figure 3.19: “Administer vaccine and tetanus immune gobulin (TIG) now.” corrected to “Administer vaccine and tetanus immune globulin (TIG) now.”
• Page 851, Tetanus chapter, Figure 3.19, footnote 1: “doses of tetanus- and diphtheriacontaining.” corrected to “doses of tetanus- and diphtheria-containing.”